[1]CurrentPatentAssignee:NANJINGUNIVERSITY-CN103724325,2016,BLocationinpatent:Paragraph0032;0033;0070;0071
[1]Shon,JongCheol;Phuc,NguyenMinh;Kim,WonCheol;Heo,JaeKyung;Wu,Zhexue;Lee,Hyunyoung;Liu,Kwang-Hyeon[BiopharmaceuticsandDrugDisposition,2017,vol.38,#9,p.553-556]
[2]Qin,Yan;Dong,Haijun;Sun,Jiayin;Zhang,Yilong;Li,Jun;Zhang,Tianci;Chen,Guanjun;Wang,Sheng;Song,Shuai;Wang,Wei;Fan,Yuru;Wang,Jie;Huang,Xiaohui;Shen,Chenlin[Xenobiotica,2021,vol.51,#12,p.1389-1399]
Title: Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study.
Journal: Biopharmaceutics & drug disposition 20120901
Title: Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.
Journal: European journal of clinical pharmacology 20120501
Title: High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
Title: Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.
Journal: European journal of clinical pharmacology 20120401
Title: [Effect of high altitude hypoxia on the activity and protein expression of CYP2C9 and CYP2C19].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20120201
Title: Prediction of relative in vivo metabolite exposure from in vitro data using two model drugs: dextromethorphan and omeprazole.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120101
Title: Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815
Title: Clinically significant CYP2C inhibition by noscapine but not by glucosamine.
Journal: Clinical pharmacology and therapeutics 20100901
Title: CYP2C19 haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole.
Journal: Journal of clinical pharmacy and therapeutics 20090801
Title: Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
Journal: Journal of clinical pharmacology 20090501
Title: Enantioseparation of omeprazole and its metabolite 5-hydroxyomeprazole using open tubular capillary electrochromatography with immobilized avidin as chiral selector.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081101
Title: Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
Journal: European journal of clinical pharmacology 20071101
Title: Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.
Journal: Acta pharmacologica Sinica 20071001
Title: Validation of chromatographic methods: evaluation of detection and quantification limits in the determination of impurities in omeprazole.
Journal: Journal of chromatography. A 20070713
Title: Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
Journal: Clinical and experimental pharmacology & physiology 20070101
Title: Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.
Journal: BMC clinical pharmacology 20070101
Title: Enantiomeric separation of omeprazole and its metabolite 5-hydroxyomeprazole using non-aqueous capillary electrophoresis.
Journal: Journal of chromatography. A 20061006
Title: Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography.
Journal: Journal of pharmaceutical and biomedical analysis 20060911
Title: Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS)--eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102
Title: Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.
Journal: Clinical pharmacology and therapeutics 20051201
Title: Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925
Title: The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
Journal: Clinical pharmacokinetics 20050101
Title: Metabolism of omeprazole after two oral doses in children 1 to 9 months old.
Journal: Proceedings of the Western Pharmacology Society 20050101
Title: Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects.
Journal: British journal of clinical pharmacology 20040901
Title: Omeprazole treatment of Korean patients: effects on gastric pH and gastrin release in relation to CYP2C19 geno- and phenotypes.
Journal: Basic & clinical pharmacology & toxicology 20040901
Title: Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.
Journal: Journal of clinical pharmacology 20040601
